NCT06295965View on ClinicalTrials.gov

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2031

Conditions
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaRecurrent Malignant Solid NeoplasmClonal Cytopenia of Undetermined SignificanceClonal HematopoiesisIdiopathic Cytopenia of Undetermined SignificanceNon-Neoplastic Hematopoietic and Lymphoid Cell DisorderOvarian CarcinomaMyeloid Neoplasm Post Cytotoxic Therapy
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (1)

98109

RECRUITING

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER